Ensysce Biosciences (ENSC) Net Margin (QoQ) (2020 - 2025)
Ensysce Biosciences (ENSC) Net Margin (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.89 Bn | 131.04 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.05 Bn | 78.06 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.38 Bn | 1.37 Bn |
| 4 | Moderna | 55.46 Bn | 50.32 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.30 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - |
| 10 | Ensysce Biosciences | 927,816.38 | -3.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -62,987.00 |
| Jun 30, 2025 | 2,103.00 |
| Mar 31, 2025 | 12,600.00 |
| Dec 31, 2024 | -29,277.00 |
| Sep 30, 2024 | 110,177.00 |
| Jun 30, 2024 | -6,293.00 |
| Mar 31, 2024 | -33,908.00 |
| Dec 31, 2023 | -6,265.00 |
| Sep 30, 2023 | -16,187.00 |
| Jun 30, 2023 | -17,776.00 |
| Mar 31, 2023 | 10,709.00 |
| Dec 31, 2022 | 315,786.00 |
| Sep 30, 2022 | 31,254.00 |
| Jun 30, 2022 | -357,926.00 |
| Mar 31, 2022 | 38,653.00 |
| Dec 31, 2021 | 76,644.00 |
| Sep 30, 2021 | -121,886.00 |
| Jun 30, 2021 | 15,179.00 |
| Mar 31, 2021 | -41,364.00 |
| Dec 31, 2020 | -13,838.00 |